Riley-Day Syndrome has active NIH research funding with 7 funded grants totaling $6.3M.
1 new grant started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Riley-Day Syndrome. Strongest funded area: Basic Science. Largest gap: Translational / Drug Development.
2 funded grants in Translational / Drug Development but only 1 related publication found for Riley-Day syndrome. This may indicate early-stage research that hasn't yet produced published results.
These grants mention Riley-Day Syndrome as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Riley-Day Syndrome.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.